Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vasopressin Receptor 1A (V1aR), encoded by the AVPR1A gene, is a G protein-coupled receptor that mediates the effects of arginine vasopressin (AVP). Primarily coupled to Gq/11 proteins, its activation leads to increased intracellular calcium levels through the phospholipase C/IP3/DAG pathway. It is widely expressed in the brain and peripheral tissues, including vasculature, liver, kidney, and heart. V1aR plays a key role in vasoconstriction, hepatic glycogenolysis, and social behaviors. Selective agonists and antagonists are used to differentiate its functions from other vasopressin receptors, such as V2 and V1b.
Gq/11 protein activation leading to phospholipase C activation, increased IP3/DAG, and raised intracellular Ca2+ levels.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vasopressin Receptor 1A (V1aR).